BDO Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$50K Buy
618
+418
+209% +$34.1K 0.01% 434
2023
Q1
$15.9K Buy
+200
New +$14.2K ﹤0.01% 619
2021
Q1
Sell
-92
Closed -$3K 1235
2020
Q4
$3K Hold
92
﹤0.01% 719
2020
Q3
$3K Buy
92
+52
+130% +$1.73K ﹤0.01% 643
2020
Q2
$1K Hold
40
﹤0.01% 663
2020
Q1
$1K Buy
+40
New +$1.19K ﹤0.01% 714
2018
Q1
Sell
-34
Closed -$1K 596
2017
Q4
$1K Buy
+34
New +$865 ﹤0.01% 463

Other funds holding NVO

BDO Wealth Advisors's NVO Position: Q2 2023 in Review

BDO Wealth Advisors increased its Novo Nordisk (NVO) stake by 209% in Q2 2023, buying an estimated $34.1K and bringing the position to 618 shares worth $50K. The position accounts for 0.01% of the portfolio, ranked #434.

BDO Wealth Advisors first reported a position in NVO in Q4 2017 and has held it in 7 quarters since. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • BDO Wealth Advisors held 618 shares of Novo Nordisk worth $50K as of Q2 2023.
  • BDO Wealth Advisors bought 418 Novo Nordisk shares in Q2 2023, an estimated $34.1K.
  • Novo Nordisk made up 0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #434 holding.
  • BDO Wealth Advisors first reported a position in Novo Nordisk in Q4 2017 and has held it in 7 quarters since.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.